PharmaVoice

JULY 6, 2022

Ratings agency Moody’s lays out the risk exposure for industry leaders.

262

262

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7. Elsewhere, San Diego, California-based Heron Therapeutics announced restructuring and layoffs for 34% of its workforce.

129

129

PharmaVoice

JULY 6, 2022

From M&Ms to biotech, the chief financial officer's sweet tooth for taking risks is paying off.

246

246

Pharmacy Times

JULY 6, 2022

Jazz Pharmaceuticals announced top-line results from the phase 3 RELEASE MSS1 trial, evaluating nabiximols oromucosal spray in individuals with multiple sclerosis.

123

123

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmaceutical Technology

JULY 6, 2022

The European Commission (EC) has granted approval for the expanded conditional marketing authorization (CMA) of Novavax’s Covid-19 vaccine, Nuvaxovid (NVX-CoV2373), in the European Union (EU) for adolescents of the age 12 to 17 years. A protein-based vaccine, NVX-CoV2373 is made from the genetic sequence of the SARS-CoV-2 virus’ first strain. The latest development comes after the Committee for Medicinal Products for Human Use of the European Medicines Agency granted a positive recommendation in

Vaccines 105

Vaccines Adverse Reactions 105

Pharmacy Times

JULY 6, 2022

After 4 years of treatment with ofatumumab, 78.8% of patients with relapsing forms of multiple sclerosis who continuously received ofatumumab achieved NEDA-3 compared to 51.8% of those who switched from teriflunomide to ofatumumab.

123

123

Pharmacy Times

JULY 6, 2022

Pravastatin sodium (Pravachol) is indicated as an adjunctive therapy to diet to lower the risk of myocardial infarction, revascularization, and cardiovascular mortality in hypercholesterolemic patients without clinically evident congenital heart disease.

123

123

pharmaphorum

JULY 6, 2022

The FDA approves new cancer treatments in half the time of the EMA – but does faster mean better? And how can regulators balance timely access with robust safety? Cancer patients in Europe wait an average of almost eight months longer for access to breakthrough medications than their American counterparts. A new cross-sectional study has found that the FDA green lit 95% of the 89 new oncology therapies approved between 2010 and 2019 before the EMA, with the Europeans trailing the Americans by a

FDA 98

FDA 98

Pharmacy Times

JULY 6, 2022

Isotretinoin exerts dose-dependent inhibition of sebaceous gland function, thereby reducing sebum secretion, which is associated with improvement in nodular acne.

122

122

pharmaphorum

JULY 6, 2022

BioNTech has responded to a patent infringement lawsuit filed by fellow German biotech CureVac over its COVID-19 vaccine, saying it will “vigorously” defend itself. CureVac revealed yesterday that had filed suit in the Düsseldorf Regional Court, claiming that mRNA technology used in BioNTech’s Comirnaty vaccine – partnered with Pfizer – infringes its intellectual property.

Vaccines 98

Vaccines 98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JULY 6, 2022

Clinical trial results show durable responses with mosunetuzumab in advanced follicular lymphoma.

FDA 114

FDA 114

Pharmaceutical Technology

JULY 6, 2022

Europe was the fastest growing region for data analytics hiring among pharmaceutical industry companies in the three months ending May. The number of roles in Europe made up 11.8% of total data analytics jobs - up from 11.1% in the same quarter last year. That was followed by North America, which saw a -0.4 year-on-year percentage point change in data analytics roles.

98

98

Pharmacy Times

JULY 6, 2022

Thrombocytopenia was the most common adverse effect, which was managed through dose reduction.

73

73

Outsourcing Pharma

JULY 6, 2022

England's cost-effectiveness watchdog has recommended Eli Lillyâs Verzenios treatment as an option for adjuvant treatment of certain forms of breast cancer.

64

64

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JULY 6, 2022

Lenacapavir is an investigational, long-acting HIV-1 capsid inhibitor that is not yet approved by any regulatory authority.

FDA 73

FDA 73

Pharmaceutical Technology

JULY 6, 2022

The proportion of pharmaceutical companies hiring for big data related positions rose in June 2022 compared with the equivalent month last year, with 68.4% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 65.7% of companies who were hiring for big data related jobs a year ago and the same as the figure of 68.4% in May 2022.

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies 64

Pharmacy Times

JULY 6, 2022

The panel describes the various roles and responsibilities for each member of an AML management care team.

65

65

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7. Elsewhere, San Diego, California-based Heron Therapeutics announced restructuring and layoffs for 34% of its workforce.

64

64

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JULY 6, 2022

Dr James McCloskey discusses patient selection for AML maintenance therapy, as well as novel agents that are being evaluated in this setting.

65

65

Compounding Pharmacy of America

JULY 6, 2022

Stress is a very normal part of everyday life, and in some respects, it is necessary for our survival. However, any life event that pushes you to experience worry, fear, or uncertainty for prolonged periods can have negative impacts on your mental and physical health. The post Mental Effects of Stress: Learning to Relax in the Face of Everyday Stress appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

Pharmacy Times

JULY 6, 2022

Zahra Mahmoudjafari, PharmD, BCOP, DPLA; Alison Gulbis, PharmD, BCOP; and Kamakshi Rao, PharmD, BCOP, FASHP, discuss research conducted looking to assess the hematology-oncology pharmacist “great migration” from the field.

65

65

Aureus Medical Group

JULY 6, 2022

Omaha, Neb., July 6, 2022 — Medical Solutions, one of the nation’s largest providers of total workforce solutions serving the healthcare industry, today announced that it has acquired Durham, NC-based Matchwell. Terms of the deal were not disclosed. Launched in 2019, Matchwell’s AI enabled marketplace and SaaS solution efficiently matches licensed and certified staff with healthcare organizations across a variety of clinical settings ranging from hospitals to skilled and assisted living fa

Long-Term Care Facilities 52

Long-Term Care Facilities Assisted Living Hospitals Patient Care 52

Pharmacy Times

JULY 6, 2022

Ken Thorpe, PhD, professor of public health at Emory University and chairman of Partnership to Fight Chronic Disease, discusses legislation that the US House of Representatives recently passed to put greater restrictions on the FDA’s accelerated approval pathway.

FDA 65

FDA 65

Fuld

JULY 6, 2022

Private Equity (PE) firms primarily focus on these three parameters. First, to understand the target firm’s true worth through the due diligence process; second, to find sustainable systems to drive significant value creation post-investment; and third, to find the right time and suitable structure for an exit. A PE firm’s success can only be measured by the opportunities it uncovers and how it gets ahead of challenges in managing the firm.

Customer Service 52

Customer Service 52

Pharmacy Times

JULY 6, 2022

Legatrin PM is intended for relief of lower body pain.

65

65

Pharmaceutical Commerce

JULY 6, 2022

The EPCIS communications standard is “recommended,” and trading partners are identified.

Communication 52

Communication FDA 52

Pharmacy Times

JULY 6, 2022

Intelligent Parcel Tracking & Planning Solution and Ensure Patient Medications Arrive On-Time.

Specialty Pharmacies 65

Specialty Pharmacies 65

PharmExec

JULY 6, 2022

Round discusses how he adjusted his leadership style and approach to patient care in the most effective way during the pandemic.

Patient Care 52

Patient Care 52

Pharmaceutical Technology

JULY 6, 2022

Business optimism improved in June 2022 compared to May 2022, even amid concerns over rising costs and slowing demand, revealed an analysis of an ongoing poll by Verdict. Verdict has been conducting the poll to study the trends in business optimism during COVID-19 as reflected by the views of companies on their future growth prospects amid the pandemic.

52

52

Outsourcing Pharma

JULY 6, 2022

The academic research center has adopted the life science technology companyâs cloud-based platform for cancer research, drug discovery, and clinical trials.

52

52

pharmaphorum

JULY 6, 2022

The FDA has started an accelerated review of Eisai and Biogen’s a new amyloid-targeting antibody lecanemab for Alzheimer’s disease, with a 6 January deadline that keep them ahead of closest rival Eli Lilly. The US regulator has been reviewing lecanemab as a treatment for patients with early-stage Alzheimer’s and amyloid plaques in the brain under a rolling biologics license application which completed in May.

FDA 52

FDA 52

Outsourcing Pharma

JULY 6, 2022

In this first of a two-part series, an expert discusses various factors behind the DCT formatâs rapid rise and likely longevity in the drug development arena.

52

52

Pharma Times

JULY 6, 2022

Clinical trial evidence suggests that Tremfya is effective when compared with a placebo

49

49